GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (NYSE:BHC) » Definitions » Cyclically Adjusted PB Ratio

BHC (Bausch Health) Cyclically Adjusted PB Ratio : 1.12 (As of Jun. 29, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Bausch Health Cyclically Adjusted PB Ratio?

As of today (2025-06-29), Bausch Health's current share price is $6.46. Bausch Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $5.76. Bausch Health's Cyclically Adjusted PB Ratio for today is 1.12.

The historical rank and industry rank for Bausch Health's Cyclically Adjusted PB Ratio or its related term are showing as below:

BHC' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.41   Med: 1.52   Max: 25.21
Current: 1.06

During the past years, Bausch Health's highest Cyclically Adjusted PB Ratio was 25.21. The lowest was 0.41. And the median was 1.52.

BHC's Cyclically Adjusted PB Ratio is ranked better than
72.69% of 747 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs BHC: 1.06

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bausch Health's adjusted book value per share data for the three months ended in Mar. 2025 was $-3.201. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.76 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted PB Ratio Chart

Bausch Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.45 0.63 0.92 1.28

Bausch Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 0.91 1.13 1.28 1.12

Competitive Comparison of Bausch Health's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PB Ratio falls into.


;
;

Bausch Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bausch Health's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6.46/5.76
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Bausch Health's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-3.201/129.1809*129.1809
=-3.201

Current CPI (Mar. 2025) = 129.1809.

Bausch Health Quarterly Data

Book Value per Share CPI Adj_Book
201506 18.775 100.500 24.133
201509 18.486 100.421 23.780
201512 17.234 99.947 22.275
201603 16.487 101.054 21.076
201606 15.439 102.002 19.553
201609 11.986 101.765 15.215
201612 9.062 101.449 11.539
201703 11.191 102.634 14.086
201706 11.279 103.029 14.142
201709 15.282 103.345 19.103
201712 16.773 103.345 20.966
201803 12.668 105.004 15.585
201806 9.917 105.557 12.136
201809 9.015 105.636 11.024
201812 7.811 105.399 9.573
201903 7.653 106.979 9.241
201906 7.384 107.690 8.858
201909 7.043 107.611 8.455
201912 3.015 107.769 3.614
202003 2.028 107.927 2.427
202006 1.335 108.401 1.591
202009 1.653 108.164 1.974
202012 1.505 108.559 1.791
202103 -0.550 110.298 -0.644
202106 -1.915 111.720 -2.214
202109 -0.568 112.905 -0.650
202112 -0.295 113.774 -0.335
202203 -0.598 117.646 -0.657
202206 -1.917 120.806 -2.050
202209 -1.451 120.648 -1.554
202212 -1.912 120.964 -2.042
202303 -2.200 122.702 -2.316
202306 -1.821 124.203 -1.894
202309 -3.232 125.230 -3.334
202312 -2.798 125.072 -2.890
202403 -3.041 126.258 -3.111
202406 -3.202 127.522 -3.244
202409 -3.193 127.285 -3.241
202412 -3.477 127.364 -3.527
202503 -3.201 129.181 -3.201

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (NYSE:BHC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bausch Health Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Carson officer: EVP, General Counsel 400 SOMERSET CORPORATE BLVD, BRIDGEWATER NJ 08807
John S Barresi officer: SVP, Controller & CAO 727 FIFTH AVENUE, NEW YORK NY 10022
Richard Mulligan director C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153
Tom George Vadaketh officer: EVP, Chief Financial Officer 1727 JOCKEYS WAY, YARDLEY PA 19067
Robert Spurr director, officer: U.S. President-Pharma Business C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Joseph F Gordon officer: Pres&Co-Head Bausch&Lomb/Int'l C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Frederick Munsch officer: SVP, Controller and CAO C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Christina Ackermann officer: EVP AND GENERAL COUNSEL C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Sam Eldessouky officer: EVP & Chief Financial Officer C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Steven D Miller director 16690 COLLINS AVENUE, PH, SUNNY ISLE BEACH FL 33160
Von Eschenbach Andrew C. director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
De Schutter Richard U director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brett Icahn director C/O ICAHN ENTERPRISES L.P., 16690 COLLINS AVE., PH, SUNNY ISLES FL 33160
William D. Humphries officer: EVP, COMPANY GROUP CHAIRMAN C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044
Valueact Capital Master Fund, L.p. director, other: See remarks ONE LETTERMAN DRIVE, BUILDING D, 4TH FLOOR, SAN FRANCISCO CA 94129